M. Berardet

Effects of active specific and non-specific immunotherapy on E male G2 leukemia according to the route of administration and combination of immunological stimulants.

J. Amiel, M. Berardet, 1971, European journal of cancer.

An experimental model of active immunotherapy preceded by cytoreductive chemotherapy.

J. Amiel, M. Berardet, 1970, European journal of cancer.

Attempts to prevent acquired immunological insufficiences in mice by Bacillus Calmette-Guérin

J. Amiel, M. Berardet, 1971, Experientia.

Modulation of immune responses in mice by oral administration of niflumic acid.

J. Maral, A. Cloarec, I. Florentin, 1989, International journal of immunopharmacology.

Essais d'immunotherapie active non specifique par corynebacterium parvum formole.

J. Amiel, M. Berardet, J. Litwin, 1969 .

Factor time for active immunotherapy after cytoreductive chemotherapy.

J. Amiel, M. Berardet, 1974, European journal of cancer.

Potentiated immune responses after administration of aclacinomycin.

G. Mathé, S. Orbach-Arbouys, M. Berardet, 1982, International Archives of Allergy and Applied Immunology.